Received Jan 16, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (NO BRAND NAME) | UNKNOWN MANUFACTURER | 1 | — | — |
Guillain -Barre syndrome; This is a solicited report received from a Consumer or other non HCP, Program ID: . A female patient received rsv vaccine prot.subunit pref 2v (RSV VACCINE PROT.SUBUNIT PREF 2V), as dose 1, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: GUILLAIN-BARRE SYNDROME (hospitalization), outcome "unknown", described as "Guillain -Barre syndrome". Therapeutic measures such as 4 antibodies infusions were taken as a result of guillain-barre syndrome . The information on the batch/lot number for rsv vaccine prot.subunit pref 2v will be requested and submitted if and when received.; Sender's Comments: As there is limited information in the case with no temporal or clinical evidence directly linking rsv vaccine prot.subunit pref 2v to the event Guillain-barre syndrome, the causality assessed as unrelated to rsv vaccine prot.subunit pref 2v.